OR WAIT null SECS
May 03, 2013
The Global Vaccine Action plan maps out a strategy to increase access and R&D for vaccines.
April 08, 2013
Regeneron, a biopharmaceutical company based in New York, has announced plans to expand its corporate headquarters and laboratories in Westchester. This expansion will create more than 400 new highly skilled jobs and further cement Hudson Valley's reputation as an emerging epicenter for biopharmaceutical growth.
Company considers investment in insulin cartridge-filling and insulin API manufacturing capacity in the US.
Teva and Lonza have announced that their joint venture will continue to develop, manufacture and market affordable, efficacious and safe biosimilars.
Company issues voluntary recall after learning of complaints of an uncharacteristic odor coming from Levoxyl bottles.
Astellas and Ambrx have entered into a collaboration to discover and develop novel antibody drug conjugates (ADCs) for an undisclosed number of targets in oncology. ADCs enable targeted delivery of drugs to the target tissue.
April 03, 2013
The Access to Medicines Index shows that pharmaceutical companies are increasing drug development for the developing world and using more tiered pricing mechanisms to lower pricing.
A roundup of developments in corporate social responsibility (CSR) and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations
April 02, 2013
Draft guidance combines and supersedes previous guidance documents.
March 27, 2013
Merck's Januvia [sitagliptin] was named 2013 Brand of the Year by Pharmaceutical Executive magazine.